| 3,3 diindolylmethane |
Influence on cell viability in presence of cisplatin |
SRB cell survival assay |
20.00 µM |
SKOV-3 |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on cell viability in presence of cisplatin |
SRB cell survival assay |
50.00 µM |
SKOV-3 |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
20.00 µM |
NOSE |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
40.00 µM |
NOSE |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
60.00 µM |
NOSE |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
80.00 µM |
NOSE |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
100.00 µM |
NOSE |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
120.00 µM |
NOSE |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
20.00 µM |
TOV-21G |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
40.00 µM |
TOV-21G |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
60.00 µM |
TOV-21G |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
80.00 µM |
TOV-21G |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
100.00 µM |
TOV-21G |
Homo sapiens |
|
|
|
| 3,3 diindolylmethane |
Influence on epithelial cell viability |
SRB cell survival assay |
120.00 µM |
TOV-21G |
Homo sapiens |
|
|
|
